ICLR: ICON Public Limited Company - Summary | Jitta

ICON Public Limited Company

NASDAQ:ICLR

Price
$207.89
Loss Chance
43.2%
6.43JITTA SCORE
112.00%Over Jitta Line
Jitta Ranking
131 / 939
1,660 / 4,286
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (57)
Recent Business Performance (52)
Financial Strength (91)
Return to Shareholders (61)
Competitive Advantage (70)
Jitta Signs
Revenue and EarningConsistent Growth in the past 5 years
Debt LevelLow Long Term Debt
Return on EquityConsistently High
CapExVery Low
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Key Stats
Jitta Score
Jitta Line
6.43
112.00%
2.30
292.60%
Life Sciences Tools and Services
5.69
579.90%
6.10
3.60%
5.39
373.39%
COMPANY DESCRIPTION
ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. The company’s clinical development services include product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. Its clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. The company was founded in 1990 and is headquartered in Dublin, Ireland.